Mark Andrews

Mark Andrews,* tight end for the Baltimore Ravens, is known for his durability, reliability, and consistency. He expects those same qualities with his pump therapy, which is why he uses Control-IQ technology.

* Tandem Diabetes Care has a compensation agreement with Mark Andrews.

Life Changing

Just as every game presents its own challenges, so does each day living with type 1 diabetes. Watch how the t:slim X2 insulin pump with Control-IQ technology changed Mark’s life.

His Diabetes Story

Mark was diagnosed with type 1 diabetes when he was 9 years old, but that never deterred him from his goal of being a professional football player. Learn more about his journey.

Pump Up

Mark’s job requires that he’s in peak physical shape. With the help of his t:slim X2 pump with Control-IQ technology, Mark can stay game-ready while still managing his type 1 diabetes.

Mark’s T1D Teammates

As one of the best tight ends in professional football, Mark Andrews has a fanbase that extends well beyond the field. They also include real t:slim X2 insulin pump users — just like him.

Mark Scores for JDRF

In the 2020 season, Mark helped Tandem Diabetes Care raise $23,400 for the JDRF Foundation through our fantasy football charity challenge.

Positively Different

“My Life is Positively Different”

Mark shares how he’s had a positively different diabetes care experience with the t:slim X2 insulin pump with Control-IQ technology.

Pro Tip #1

Set a Personal Profile

With up to six Personal Profiles available, Mark encourages you to go to your healthcare provider and find one that fits your unique lifestyle.

Pro Tip #2

Follow Your Dreams

Mark didn’t let having type 1 diabetes get in the way of following his dreams and he wants fans of all ages to pursue their aspirations.

A TD For T1D

When Mark Andrews and Blake Ferguson met on November 11, 2021 in Miami, it was believed the first time two professional athletes living with T1D shared the gridiron at the same time. Blake’s team came out ahead, but Mark hauled in six catches for 63 yards and a touchdown.

Control-IQ Technology

Trying to keep your blood sugar in range can be stressful and time consuming. Our Control-IQ advanced hybrid closed-loop technology makes it easier by predicting and helping to prevent highs and lows to help increase time in range.^†

Learn More

Changing People’s Lives

Control-IQ technology has been a game-changer for Mark Andrews, but he’s not the only one. Our customers have been sharing how Control-IQ technology has provided them with better sleep, increased ease of use, and greater control.

Watch Videos

Responsible Use of Control‑IQ Technology

Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Because there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider's recommendations.

† As measured by CGM.

Important Safety Information

RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with U-100 insulin only. t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

Warning: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

Select Country

Tandem Ambassador

Tight end for the Baltimore Ravens